Floatz logo

Anti-Thymoglobulin, Rabbit

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome

M.D. Anderson Cancer CenterPhase 2Active
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
81/ 100

Competitive context

35 Active assets in the Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
National Cancer Institute (NCI)
Phase 3BB
Daunorubicin
Institut de Recherches Internationales Servier
Phase 3BB
ETOPOSIDE
Institut de Recherches Internationales Servier
Phase 2BB
Decitabine
National Cancer Institute (NCI)
Phase 3BB
ag-120
Institut de Recherches Internationales Servier
Phase 3BB

View all 50 →

Same molecule, other indications

Anti-Thymoglobulin, Rabbit is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
72 / 100
View asset →
myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →